Magnesium in Aneurysmal Subarachnoid Hemorrhage "MASH-1"

Completed

Phase N/A Results

Summary of Purpose

To determine whether magnesium and/or acetylsalicylic acid reduce the frequency of delayed cerebral ischemia in patients with acute aneurysmal subarachnoid hemorrhage (SAH).

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 14 August 2008.

Unavailable Unavailable Unavailable Unavailable Unavailable Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Sponsors

  • The Netherlands Heart Foundation

Trial Design

Randomized, placebo-controlled, multicenter, factorial trial.

Contacts

Not available